Copyright
©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 403-417
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.403
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.403
Characteristics | Total (n = 689) | GNRI tertile 1 (n = 230) | GNRI tertile 2 (n = 230) | GNRI tertile 3 (n = 229) | F/H/χ2 | P value |
Women [n (%)] | 295 (42.8) | 109 (47.4) | 96 (41.7) | 90 (39.3) | 3.065 | 0.080 |
Age (yr) | 55.59 ± 10.88 | 58.02 ± 10.49 | 56.00 ± 10.84 | 52.74 ± 10.69 | 28.071 | < 0.001 |
Height (cm) | 166.89 ± 8.24 | 165.25 ± 7.88 | 167.10 ± 8.52 | 168.33 ± 8.06 | 16.410 | < 0.001 |
Weight (kg) | 70.00 (62.00-80.00) | 62.00 (56.00-69.00) | 71.00 (64.75-78.85) | 80.00 (72.75-90.00) | 16.636 | < 0.001 |
Diabetes duration (yr) | 7.33 ± 6.20 | 8.96 ± 6.42 | 7.58 ± 6.44 | 5.45 ± 5.15 | 38.741 | < 0.001 |
BMI (kg/m2) | 25.39 (23.23-27.78) | 22.92 (21.31-24.49) | 25.53 (24.20-26.93) | 28.28 (26.62-30.47) | 19.284 | < 0.001 |
SBP (mmHg) | 133.84 ± 15.34 | 132.96 ± 16.80 | 133.89 ± 15.98 | 134.67 ± 12.98 | 1.420 | 0.234 |
DBP (mmHg) | 81.00 ± 9.88 | 79.44 ± 10.19 | 80.76 ± 9.50 | 82.79 ± 9.70 | 13.343 | < 0.001 |
Hypertension [n (%)] | 333 (48.3) | 112 (48.7) | 117 (50.9) | 104 (45.4) | 0.492 | 0.483 |
GNRI (score) | 105.61 (99.64-112.01) | 97.09 (93.02-99.66) | 105.62 (103.73-107.68) | 114.25 (112.01-119.37) | 27.818 | < 0.001 |
Glucose-lowering therapies [n (%)] | ||||||
Lifestyle alone | 121 (17.6) | 31 (13.5) | 36 (15.7) | 54 (23.6) | 8.071 | 0.004 |
Insulin treatments | 248 (36.0) | 102 (44.3) | 89 (38.7) | 57 (24.9) | 18.817 | < 0.001 |
Insulin secretagogues | 222 (32.2) | 83 (36.1) | 78 (33.9) | 61 (26.6) | 4.681 | 0.030 |
Insulin sensitizers | 79 (11.5) | 25 (10.9) | 28 (12.2) | 26 (11.4) | 0.027 | 0.870 |
Metformin | 322 (46.7) | 88 (38.3) | 110 (47.8) | 124 (54.1) | 11.622 | < 0.001 |
AGIs | 105 (15.2) | 23 (10.0) | 33 (14.3) | 49 (21.4) | 11.519 | < 0.001 |
DPP-4Is | 57 (8.3) | 18 (7.8) | 23 (10.0) | 16 (7.0) | 0.105 | 0.745 |
SGLT-2Is | 93 (13.5) | 28 (12.2) | 35 (15.2) | 30 (13.1) | 0.085 | 0.771 |
GLP-1RAs | 41 (6.0) | 3 (1.3) | 14 (6.1) | 24 (10.5) | 17.240 | < 0.001 |
Statins | 122 (17.7) | 37 (16.1) | 45 (19.6) | 40 (17.5) | 0.151 | 0.698 |
Laboratory findings | ||||||
HbA1c (%) | 8.99 ± 1.85 | 9.50 ± 2.02 | 8.92 ± 1.63 | 8.53 ± 1.75 | 33.073 | < 0.001 |
Albumin (g/L) | 38.50 (36.20-41.30) | 35.90 (33.88-37.63) | 38.60 (37.00-40.60) | 41.70 (39.45-44.00) | 17.954 | < 0.001 |
Cr (µmol/L) | 58.51 ± 21.32 | 58.22 ± 25.22 | 57.85 ± 21.58 | 59.46 ± 16.26 | 0.386 | 0.535 |
UA (µmol/L) | 312.68 ± 99.25 | 279.47 ± 103.09 | 314.02 ± 89.46 | 344.68 ± 94.19 | 53.222 | < 0.001 |
TG (mmol/L) | 1.89 (1.18-3.11) | 1.46 (0.98-2.33) | 1.81 (1.15-2.83) | 2.38 (1.58-3.98) | 7.626 | < 0.001 |
TC (mmol/L) | 4.41 ± 1.06 | 4.29 ± 1.01 | 4.33 ± 0.98 | 4.62 ± 1.15 | 10.890 | 0.001 |
HDL-C (mmol/L) | 1.14 ± 0.27 | 1.15 ± 0.28 | 1.15 ± 0.25 | 1.10 ± 0.27 | 3.679 | 0.056 |
LDL-C (mmol/L) | 2.81 ± 0.87 | 2.80 ± 0.88 | 2.80 ± 0.82 | 2.84 ± 0.91 | 0.309 | 0.578 |
TBil (µmol/L) | 11.21 ± 4.71 | 10.25 ± 4.60 | 11.43 ± 4.68 | 11.95 ± 4.70 | 15.213 | < 0.001 |
OS (ng/mL) | 11.85 ± 3.99 | 12.06 ± 4.26 | 11.88 ± 3.89 | 11.60 ± 3.82 | 1.508 | 0.220 |
β-CTX (ng/mL) | 0.45 ± 0.22 | 0.51 ± 0.25 | 0.44 ± 0.21 | 0.41 ± 0.19 | 25.645 | < 0.001 |
TP1NP (ng/mL) | 40.73 ± 14.53 | 41.00 ± 14.00 | 40.74 ± 14.66 | 40.45 ± 14.98 | 0.165 | 0.685 |
DXA parameters (g/cm2) | ||||||
LS-BMD | 0.97 ± 0.16 | 0.92 ± 0.14 | 0.99 ± 0.17 | 0.99 ± 0.15 | 22.118 | < 0.001 |
FN-BMD | 0.77 ± 0.12 | 0.73 ± 0.12 | 0.79 ± 0.13 | 0.81 ± 0.11 | 53.333 | < 0.001 |
H-BMD | 0.91 ± 0.13 | 0.85 ± 0.12 | 0.91 ± 0.13 | 0.95 ± 0.12 | 83.980 | < 0.001 |
T-BMD | 1.10 ± 0.12 | 1.07 ± 0.12 | 1.10 ± 0.12 | 1.12 ± 0.11 | 21.875 | < 0.001 |
Body composition | ||||||
Total body fat (%) | 31.03 ± 6.56 | 29.03 ± 6.55 | 30.80 ± 5.83 | 33.26 ± 6.62 | 51.017 | < 0.001 |
Android/gynoid ratio | 1.31 ± 0.22 | 1.23 ± 0.22 | 1.33 ± 0.21 | 1.36 ± 0.20 | 49.682 | < 0.001 |
Fat mass index (kg/m2) | 7.53 (6.20-9.09) | 6.33 (5.08-7.53) | 7.54 (6.44-8.74) | 8.91 (7.51-10.75) | 13.010 | < 0.001 |
Lean mass index (kg/m2) | 16.95 (15.53-18.54) | 15.66 (14.44-16.83) | 17.11 (15.92-18.39) | 18.60 (16.99-19.90) | 14.055 | < 0.001 |
ASMI (kg/m2) | 7.09 ± 1.17 | 6.38 ± 0.91 | 7.09 ± 0.97 | 7.79 ± 1.1 | 218.066 | < 0.001 |
- Citation: Zhu XX, Yao KF, Huang HY, Wang LH. Associations between Geriatric Nutrition Risk Index, bone mineral density and body composition in type 2 diabetes patients. World J Diabetes 2024; 15(3): 403-417
- URL: https://www.wjgnet.com/1948-9358/full/v15/i3/403.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i3.403